OBJECTIVES: Potential celiac disease (CD) patients are at an increased risk to developing CD as indicated by positive CD-associated serology. We investigated in duodenal mucosa of such patients the presence of both IL-21 and IL-17A and the role of gliadin peptides and IL-15 in their expression. METHODS: Duodenal biopsies from 76 active CD, 90 potential CD, and 58 control patients were analyzed for IL-21 and/or IL-17A production by quantitative real-time PCR, immunohistochemistry, flow cytometry, and ELISA. The presence of IL-21 receptor was investigated by western blot. Potential CD duodenal fragments were cultured with gliadin peptides (PTG) and/or IL-15 and the expression/production of IL-21 and IL-17A assessed by quantitative real-time PCR and by immunohistochemistry. RESULTS: In potential CD, IL-21 was lower than in active CD, in terms of RNA expression (P<0.01), density of lamina propria (LP) IL-21(+) cells (P<0.05), and protein secretion (P<0.05). Also, IL-21R was weakly detectable in potential CD. Several LP cell types produced IL-21 in CD. In potential CD, CD4(+)IL-21(+) cells increased after PMA-ionomycin stimulation and co-produced IFN-γ but not IL-17A. After 24 hours of culture stimulation with PTG, IL-21-producing cells increased but not the ones producing IL-17A. This increase was further enhanced by the addition of IL-15 to culture medium. CONCLUSIONS: In potential CD, IL-21 is less expressed than in active CD; however, IL-21-producing cells are present and prone to respond after specific stimuli. This suggests a key role of IL-21 in the progression of mucosal damage in CD.
OBJECTIVES: Potential celiac disease (CD) patients are at an increased risk to developing CD as indicated by positive CD-associated serology. We investigated in duodenal mucosa of such patients the presence of both IL-21 and IL-17A and the role of gliadin peptides and IL-15 in their expression. METHODS: Duodenal biopsies from 76 active CD, 90 potential CD, and 58 control patients were analyzed for IL-21 and/or IL-17A production by quantitative real-time PCR, immunohistochemistry, flow cytometry, and ELISA. The presence of IL-21 receptor was investigated by western blot. Potential CD duodenal fragments were cultured with gliadin peptides (PTG) and/or IL-15 and the expression/production of IL-21 and IL-17A assessed by quantitative real-time PCR and by immunohistochemistry. RESULTS: In potential CD, IL-21 was lower than in active CD, in terms of RNA expression (P<0.01), density of lamina propria (LP) IL-21(+) cells (P<0.05), and protein secretion (P<0.05). Also, IL-21R was weakly detectable in potential CD. Several LP cell types produced IL-21 in CD. In potential CD, CD4(+)IL-21(+) cells increased after PMA-ionomycin stimulation and co-produced IFN-γ but not IL-17A. After 24 hours of culture stimulation with PTG, IL-21-producing cells increased but not the ones producing IL-17A. This increase was further enhanced by the addition of IL-15 to culture medium. CONCLUSIONS: In potential CD, IL-21 is less expressed than in active CD; however, IL-21-producing cells are present and prone to respond after specific stimuli. This suggests a key role of IL-21 in the progression of mucosal damage in CD.
Authors: G Mazzarella; M Maglio; F Paparo; G Nardone; R Stefanile; L Greco; Y van de Wal; Y Kooy; F Koning; S Auricchio; R Troncone Journal: Gut Date: 2003-01 Impact factor: 23.059
Authors: Silvia Fernández; Ignacio J Molina; Pilar Romero; Rafael González; José Peña; Francisco Sánchez; Fernanda R Reynoso; Juan L Pérez-Navero; Orlando Estevez; Consuelo Ortega; Manuel Santamaría Journal: Am J Gastroenterol Date: 2011-01-04 Impact factor: 10.864
Authors: M Sarra; M L Cupi; I Monteleone; E Franzè; G Ronchetti; A Di Sabatino; P Gentileschi; L Franceschilli; P Sileri; G Sica; G Del Vecchio Blanco; M Cretella; O A Paoluzi; G R Corazza; F Pallone; G Monteleone Journal: Mucosal Immunol Date: 2012-07-11 Impact factor: 7.313
Authors: Cezary Ciszewski; Valentina Discepolo; Alain Pacis; Nick Doerr; Olivier Tastet; Toufic Mayassi; Mariantonia Maglio; Asjad Basheer; Laith Q Al-Mawsawi; Peter H R Green; Renata Auricchio; Riccardo Troncone; Thomas A Waldmann; Nazli Azimi; Yutaka Tagaya; Luis B Barreiro; Bana Jabri Journal: Gastroenterology Date: 2019-10-14 Impact factor: 22.682